lar levels of H 2 O 2 (4); (ii) alterations in cell proliferation and Peroxisome proliferators increase hepatocyte proliferation cell cycle control (5,6); (iii) inhibition of apoptosis (7,8); (iv) and cause liver tumors in rodents, yet the mechanism of a combination of these events. action is not understood. Based on studies with null mice
The role of oxidative damage in peroxisome proliferatorit is known that peroxisome proliferator-activated receptorinduced carcinogenesis has been contested, in part due to a α (PPARα) is involved. There is also evidence that Kupffer lack of correlation between peroxisome proliferation and cells play a central role in peroxisome proliferator-induced tumorigenicity of di(2-ethylhexyl)phthalate (DEHP), a relacarcinogenesis, most likely via mechanisms involving tively weak peroxisome proliferator, versus WY-14,643, a increases in superoxide, activation of nuclear factor κB and relatively potent peroxisome proliferator (5). In contrast, a production of tumor necrosis factor-α (TNFα). However, it good correlation between increased replicative DNA synthesis is not known whether PPARα is constitutively expressed associated with hyperplasia and the carcinogenicity of peroxiin Kupffer cells. Therefore, the expression of PPAR isoforms some proliferators has been reported (5), however, signaling in rat Kupffer and parenchymal cells was examined.
events involved in stimulation of the cell cycle and its Kupffer cells and hepatocytes of >99% purity were isolated contribution to tumor formation remain unclear. Alternatively, from rats fed either a control diet or one containing 0.1% since peroxisome proliferators inhibit apoptosis both in vivo WY-14,643 for 1 week. Protein and RNA were obtained (9) and in vitro (7,8), it is possible that inhibition of proand PPAR expression was analyzed using northern and grammed cell death may predispose cells to ultimately form western blots. PPARα, PPARβ and PPARγ mRNA was tumors, especially given the increase in signals for cell replicadetected in purified hepatocytes. In Kupffer cells, mRNA tion (10). encoding PPARγ was present while transcripts for PPARα It has been proposed that Kupffer cells are causally responsand PPARβ were not detected. Immunoblots were consistible for the mitogenic effects of peroxisome proliferators (11). ent with the results found by northern analysis. Moreover, Specifically, the increase in tumor necrosis factor-α (TNFα) when Kupffer cells from wild-type or PPARα-null mice mRNA due to the peroxisome proliferator WY-14,643 is were treated with WY-14,643 in vitro, superoxide producblocked by methyl palmitate and glycine, agents that inactivate tion was similar. Combined, these results show that PPARα Kupffer cells (12, 13) . Moreover, an increase in cell proliferation is expressed in rat parenchymal cells but not in Kupffer in liver due to WY-14,643 is blocked by antibodies to TNFα cells. These data are consistent with the hypothesis that (14) . In addition, WY-14,643 activates the transcription factor parenchymal cells respond to Kupffer cell-derived TNFα nuclear factor κB (NF-κB), which is pivotal in TNFα producvia mechanisms dependent on PPARα within the parenchytion, rapidly and nearly exclusively in the Kupffer cell fraction mal cells. (15) . Finally, WY-14,643 directly activates superoxide production and protein kinase C in isolated Kupffer cells (16) . Taken together, there is considerable evidence in support of the Peroxisome proliferators are a diverse class of structurally hypothesis that peroxisome proliferators activate Kupffer cells unrelated compounds that cause marked increases in cell to produce mitogenic levels of TNFα via mechanisms dependproliferation, elevate activity of enzymes associated with ent on oxidants and NF-κB. On the other hand, experiments peroxisomal, microsomal and mitochondrial fatty acid oxida-
with null mice unequivocally demonstrate that hepatocellular tion and ultimately result in liver tumors in rodents (1, 2) . proliferation and tumors due to peroxisome proliferators require PPARα (3). It is not clear how these possibilities can co-exist. Total RNA was isolated using TRIZOL reagent (Gibco BRL, Grand Island, NY) using the manufacturer's instructions. Northern analysis of PPARα, PPARβ, PPARγ and β-actin mRNA was performed using mouse cDNA probes as described previously (22). Representative data of four separate experiments. Fig. 1 . Determination of purity of hepatocytes and Kupffer cells. Cells were isolated from female Sprague-Dawley rat (weighing~250 g; Charles River Breeding Laboratories) liver as described elsewhere (17) (19) . After the purity of each State University) and a polyclonal antibody against PPARγ (Affinity preparation was established, proteins and total cellular RNA BioReagents, Golden, CO) were used for detection of PPAR isoforms, were extracted from freshly prepared cells and used for western followed by anti-mouse or anti-rabbit secondary horseradish peroxidaseconjugated antibodies. Immunoreactive proteins were detected using ECL or northern blotting, respectively. Northern analysis of mRNA from hepatocytes showed that PPARα and PPARγ were present at high levels and a weaker signal was found for PPARβ (Figure 2 ). In contrast, mRNA for PPARα and PPARβ were was very high compared with the relative mRNA expression observed in the Kupffer cell samples. While WY-14,643 undetectable in Kupffer cells, while a signal of similar intensity to that observed in hepatocytes was found for PPARγ (Figure treatment resulted in an~2-fold increase in PPARα mRNA in hepatocytes it did not increase signals for either mRNA or 2). Western analysis of protein isolated from hepatocytes was consistent with the results obtained from RNA analysis. In protein for PPARα in Kupffer cells. Western analysis using two different commercial antibodies against PPARβ were hepatocytes, PPARα and PPARγ were both detected ( Figure  3) . In Kupffer cells, PPARα was not detected in the immunoinconclusive (data not shown) since they reacted with negative controls (samples obtained from PPARβ-null mice). blots, but PPARγ was present (Figure 3) . The signal for PPARγ
Expression of PPARα in parenchymal cells
wild-type and PPARα-null mice and superoxide production was measured (16) . Basal rates of superoxide production were not different in Kupffer cells from wild-type and PPARα-null mice (Figure 4) . Additionally, stimulation of superoxide production by either phorbol 12-myristate 13-acetate (PMA) or WY-14,643 resulted in similar increases in Kupffer cells from either wild-type or PPARα-null mice (Figure 4 ). This demonstrates that activation of Kupffer cells by peroxisome proliferators is not dependent on Kupffer cell PPARα. These data support the hypothesis that PPARα is not involved in activation of Kupffer cells by peroxisome proliferators.
Peritoneal macrophages, a cell type with a common lineage to the Kupffer cell, have been shown to possess PPARγ but not PPARα (21). The results presented suggest that PPARα does not alter gene expression in Kupffer cells in response to peroxisome proliferators since neither the protein nor mRNA were found in these cells. Since both PPARα-dependent 
